Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver - PubMed (original) (raw)
Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver
J G Fan et al. World J Gastroenterol. 2001 Oct.
No abstract available
Figures
Figure 1
The expression of hepatic PAI-1 mRNA.1, 2: control group; 3, 4, 5: model group; M: marker
Figure 2
The expression of hepatic β-action mRNA.1, 2: control group; 3, 4, 5: model group; M: marker
Similar articles
- [Effects of pravastatin on hepatic plasminogen activator inhibitor 1 mRNA expression in rabbits with fatty liver].
Fan J, Chen L, Zeng M. Fan J, et al. Zhonghua Gan Zang Bing Za Zhi. 2000 Apr;8(2):70-2. Zhonghua Gan Zang Bing Za Zhi. 2000. PMID: 10861105 Chinese. - Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model.
Rosselli MS, Burgueño AL, Carabelli J, Schuman M, Pirola CJ, Sookoian S. Rosselli MS, et al. Atherosclerosis. 2009 Sep;206(1):119-26. doi: 10.1016/j.atherosclerosis.2009.01.026. Epub 2009 Jan 29. Atherosclerosis. 2009. PMID: 19230890 - Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S. Ota T, et al. Gastroenterology. 2007 Jan;132(1):282-93. doi: 10.1053/j.gastro.2006.10.014. Epub 2006 Oct 12. Gastroenterology. 2007. PMID: 17241878 - Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin.
Nordt TK, Bode C, Sobel BE. Nordt TK, et al. Diabetologia. 2001 Sep;44(9):1121-4. doi: 10.1007/s001250100618. Diabetologia. 2001. PMID: 11596666
Cited by
- Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.
Fan JG, Zhong L, Xu ZJ, Tia LY, Ding XD, Li MS, Wang GL. Fan JG, et al. World J Gastroenterol. 2003 Sep;9(9):2045-9. doi: 10.3748/wjg.v9.i9.2045. World J Gastroenterol. 2003. PMID: 12970903 Free PMC article. - Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits.
Li C, Tu Y, Liu TR, Guo ZG, Xie D, Zhong JK, Fan YZ, Lai WY. Li C, et al. Int J Mol Med. 2015 Mar;35(3):715-23. doi: 10.3892/ijmm.2015.2072. Epub 2015 Jan 19. Int J Mol Med. 2015. PMID: 25604880 Free PMC article. - Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.
Nseir W, Shalata A, Marmor A, Assy N. Nseir W, et al. Dig Dis Sci. 2011 Dec;56(12):3439-49. doi: 10.1007/s10620-011-1767-y. Epub 2011 Jun 8. Dig Dis Sci. 2011. PMID: 21655948 Review. - Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy.
Barbato A, Iacone R, Tarantino G, Russo O, Sorrentino P, Avallone S, Galletti F, Farinaro E, Della Valle E, Strazzullo P; Olivetti Heart Study Research Group. Barbato A, et al. Intern Emerg Med. 2009 Aug;4(4):315-23. doi: 10.1007/s11739-009-0240-9. Epub 2009 Apr 7. Intern Emerg Med. 2009. PMID: 19350365
References
- Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med. 2000;32 Suppl 1:78–84. - PubMed
- Nordt TK, Peter K, Ruef J, Kübler W, Bode C. Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease. Thromb Haemost. 1999;82 Suppl 1:14–18. - PubMed
- Mezzano D, Muñoz X, Martínez C, Cuevas A, Panes O, Aranda E, Guasch V, Strobel P, Muñoz B, Rodríguez S, et al. Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine. Thromb Haemost. 1999;81:913–917. - PubMed
- Inuzuka S, Ueno T, Torimura T, Tamaki S, Sugawara H, Sakata R, Kusaba N, Sata M, Tanikawa K. The significance of colocalization of plasminogen activator inhibitor-1 and vitronectin in hepatic fibrosis. Scand J Gastroenterol. 1997;32:1052–1060. - PubMed
- Piscaglia F, Siringo S, Hermida RC, Legnani C, Valgimigli M, Donati G, Palareti G, Gramantieri L, Gaiani S, Burroughs AK, et al. Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices. Hepatology. 2000;31:349–357. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources